As of 2026-01-01, the EV/EBITDA ratio of Insmed Inc (INSM) is -38.74. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. INSM's latest enterprise value is 37,511.16 mil USD. INSM's TTM EBITDA according to its financial statements is -968.21 mil USD. Dividing these 2 quantities gives us the above INSM EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.8x - 15.4x | 15.2x |
| Forward P/E multiples | 15.6x - 19.2x | 15.9x |
| Fair Price | (72.58) - (71.58) | (72.44) |
| Upside | -141.7% - -141.1% | -141.6% |
| Date | EV/EBITDA |
| 2025-12-24 | -39.49 |
| 2025-12-23 | -39.34 |
| 2025-12-22 | -39.12 |
| 2025-12-19 | -38.92 |
| 2025-12-18 | -37.09 |
| 2025-12-17 | -44.12 |
| 2025-12-16 | -44.61 |
| 2025-12-15 | -43.78 |
| 2025-12-12 | -43.80 |
| 2025-12-11 | -43.41 |
| 2025-12-10 | -42.23 |
| 2025-12-09 | -43.18 |
| 2025-12-08 | -43.70 |
| 2025-12-05 | -45.34 |
| 2025-12-04 | -45.57 |
| 2025-12-03 | -45.95 |
| 2025-12-02 | -45.92 |
| 2025-12-01 | -46.97 |
| 2025-11-28 | -46.17 |
| 2025-11-26 | -45.45 |
| 2025-11-25 | -46.45 |
| 2025-11-24 | -45.99 |
| 2025-11-21 | -44.19 |
| 2025-11-20 | -44.38 |
| 2025-11-19 | -45.25 |
| 2025-11-18 | -44.82 |
| 2025-11-17 | -43.89 |
| 2025-11-14 | -42.97 |
| 2025-11-13 | -42.47 |
| 2025-11-12 | -43.23 |
| 2025-11-11 | -43.07 |
| 2025-11-10 | -42.68 |
| 2025-11-07 | -42.19 |
| 2025-11-06 | -41.31 |
| 2025-11-05 | -41.57 |
| 2025-11-04 | -40.67 |
| 2025-11-03 | -41.43 |
| 2025-10-31 | -42.17 |
| 2025-10-30 | -43.19 |
| 2025-10-29 | -37.18 |
| 2025-10-28 | -36.82 |
| 2025-10-27 | -36.54 |
| 2025-10-24 | -35.58 |
| 2025-10-23 | -35.68 |
| 2025-10-22 | -35.74 |
| 2025-10-21 | -36.82 |
| 2025-10-20 | -37.39 |
| 2025-10-17 | -36.92 |
| 2025-10-16 | -36.35 |
| 2025-10-15 | -36.43 |